Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Kinetics, Efficacy and Safety of IVIG-L (Human Normal Intravenous Immunoglobulin for Intravenous Use) in Hypogammaglobulinemia Patients

NCT00138697 is registered in ClinicalTrials.gov with Prothya Biosolutions as lead sponsor.

NCT NCT00138697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00138697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Kinetics, Efficacy and Safety of IVIG-L (Human Normal Intravenous Immunoglobulin for Intravenous Use) in Hypogammaglobulinemia Patients
Lead sponsor
Prothya Biosolutions
Phase
Phase 2/3
Overall status
Completed
Start date
May 31, 2001
Completion date
December 31, 2004
Enrollment
15
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hypogammaglobulinemia